Dan Yu

发表

FGF21 exerts comparable pharmacological efficacy with Adalimumab in ameliorating collagen-induced rheumatoid arthritis by regulating systematic inflammatory response.

Dan Yu, X. Ye, Ruixiang Che, 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

FGF21 attenuates pulmonary fibrogenesis through ameliorating oxidative stress in vivo and in vitro.

Dan Yu, Shengqi Zhang, Hongsong Wu, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway

Dan Yu, X. Ye, Qiang Wu, 2016, Endocrine.

[Optimization and characterization of a novel FGF21 mutant].

Dan Yu, X. Ye, G. Ren, 2012, Yao xue xue bao = Acta pharmaceutica Sinica.

FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy

Yuquan Wei, Dan Yu, X. Ye, 2016, Molecular and Cellular Biochemistry.

An efficient large-scale refolding technique for recovering biologically active recombinant human FGF-21 from inclusion bodies.

Dan Yu, X. Ye, Qiang Wu, 2019, International journal of biological macromolecules.

Pilot-scale production and characterization of PEGylated human FGF-21 analog.

Dan Yu, X. Ye, Qiang Wu, 2016, Journal of biotechnology.

Long-lasting hypoglycemic effect of modified FGF-21 analog with polyethylene glycol in type 1 diabetic mice and its systematic toxicity.

Dan Yu, X. Ye, Qiang Wu, 2016, European journal of pharmacology.

Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.

Han Liu, Dan Yu, Liying Song, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

A novel fusion protein attenuates collagen–induced arthritis by targeting interleukin 17A and tumor necrosis factor &agr;

Han Liu, Dan Yu, Liying Song, 2018, International journal of pharmaceutics.

Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model

Qingzhong Yu, Dan Yu, G. Ren, 2015, Technology in cancer research & treatment.

Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice

Dan Yu, X. Ye, Qiang Wu, 2015, Endocrine.

The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway.

Dan Yu, X. Ye, Qiang Wu, 2016, Immunology letters.

Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy.

Dan Yu, Ruixiang Che, Liying Song, 2016, Virus research.

FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy

Yuquan Wei, Dan Yu, X. Ye, 2016, Molecular and Cellular Biochemistry.

FGF21 alleviates chronic inflammatory injury in the aging process through modulating polarization of macrophages.

W. Xiao, Dan Yu, G. Ren, 2021, International immunopharmacology.

Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.

Dan Yu, X. Ye, Qiang Wu, 2017, Journal of diabetes and its complications.

The pharmacological efficacy of the anti-IL17 scFv and sTNFR1 bispecific fusion protein in inflammation mouse stimulated by LPS.

Dan Yu, Ruixiang Che, Liying Song, 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Comparison of PEGylated FGF-21 with insulin glargine for long-lasting hypoglycaemic effect in db/db mice.

Dan Yu, X. Ye, J. Qi, 2015, Diabetes & metabolism.